Secondary acute myeloid leukemia: time to turn the page von Récher, Christian

Volltext

Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy von Moschoi, Ruxanda, Imbert, Véronique, Nebout, Marielle, Chiche, Johanna, Mary, Didier, Prebet, Thomas, Saland, Estelle, Castellano, Rémy, Pouyet, Laurent, Collette, Yves, Vey, Norbert, Chabannon, Christian, Recher, Christian, Sarry, Jean-Emmanuel, Alcor, Damien, Peyron, Jean-François, Griessinger, Emmanuel

Volltext

Eprenetapopt Plus Azacitidine in TP53 -Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM) von Cluzeau, Thomas, Sebert, Marie, Rahmé, Ramy, Cuzzubbo, Stefania, Lehmann-Che, Jacqueline, Madelaine, Isabelle, Peterlin, Pierre, Bève, Blandine, Attalah, Habiba, Chermat, Fatiha, Miekoutima, Elsa, Rauzy, Odile Beyne, Recher, Christian, Stamatoullas, Aspasia, Willems, Lise, Raffoux, Emmanuel, Berthon, Céline, Quesnel, Bruno, Loschi, Michael, Carpentier, Antoine F, Sallman, David A, Komrokji, Rami, Walter-Petrich, Anouk, Chevret, Sylvie, Ades, Lionel, Fenaux, Pierre

Volltext

The beginning of a new therapeutic era in acute myeloid leukemia von Récher, Christian

Volltext

CPX-351 in FLT3-mutated acute myeloid leukemia von Andrews, Claire, Pullarkat, Vinod, Recher, Christian

Volltext

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure von PREBET, Thomas, GORE, Steven D, QUESNEL, Bruno, BEACH, C. L, FENAUX, Pierre, VEY, Norbert, ESTERNI, Benjamin, GARDIN, Claude, ITZYKSON, Raphael, THEPOT, Sylvain, DREYFUS, François, RAUZY, Odile Beyne, RECHER, Christian, ADES, Lionel

Volltext

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study von Berthon, Céline, MD, Raffoux, Emmanuel, MD, Thomas, Xavier, MD, Vey, Norbert, Prof, Gomez-Roca, Carlos, MD, Yee, Karen, MD, Taussig, David Christopher, MD, Rezai, Keyvan, PhD, Roumier, Christophe, PharmD, Herait, Patrice, MD, Kahatt, Carmen, MD, Quesnel, Bruno, Prof, Michallet, Mauricette, Prof, Recher, Christian, Prof, Lokiec, François, ScD, Preudhomme, Claude, Prof, Dombret, Hervé, Prof

Volltext

Hematidrosis as a manifestation of COVID‐19 containment‐induced stress von Récher, Christian

Volltext

Clinical Implications of Inflammation in Acute Myeloid Leukemia von Récher, Christian

Volltext

The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias von Paolillo, Rosa, Boulanger, Mathias, Gâtel, Pierre, Gabellier, Ludovic, De Toledo, Marion, Tempé, Denis, Hallal, Rawan, Akl, Dana, Moreaux, Jérôme, Baik, Hayeon, Gueret, Elise, Recher, Christian, Sarry, Jean-Emmanuel, Cartron, Guillaume, Piechaczyk, Marc, Bossis, Guillaume

Volltext

Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy von Pabst, Thomas, Vey, Norbert, Adès, Lionel, Bacher, Ulrike, Bargetzi, Mario, Fung, Samson, Gaidano, Gianluca, Gandini, Domenica, Hultberg, Anna, Johnson, Amy, Ma, Xuewen, Müller, Rouven, Nottage, Kerri, Papayannidis, Cristina, Recher, Christian, Riether, Carsten, Shah, Priya, Tryon, Jeffrey, Xiu, Liang, Ochsenbein, Adrian F

Volltext

Revisiting coexisting chromosomal abnormalities in NPM1-mutated AML in light of the revised ELN 2022 classification von Angenendt, Linus, Röllig, Christoph, Montesinos, Pau, Ravandi, Farhad, Juliusson, Gunnar, Récher, Christian, Itzykson, Raphaël, Ráčil, Zdeněk, Wei, Andrew H., Schliemann, Christoph

Volltext

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm von De Botton, Stéphane, Récher, Christian, Cortes, Jorge, Curti, Antonio, Fenaux, Pierre, Peterlin, Pierre, Pigneux, Arnaud, Yee, Karen, Wei, Andrew, Mims, Alice, Schiller, Gary, Chao, Mwe Mwe, Tian, Hua, Watts, Justin M

Volltext

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice von Sarry, Jean-Emmanuel, Murphy, Kathleen, Perry, Robin, Sanchez, Patricia V, Secreto, Anthony, Keefer, Cathy, Swider, Cezary R, Strzelecki, Anne-Claire, Cavelier, Cindy, Récher, Christian, Mansat-De Mas, Véronique, Delabesse, Eric, Danet-Desnoyers, G, Carroll, Martin

Volltext

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial von FADERL, Stefan, WETZLER, Meir, MARIS, Michael, KOVACSOVICS, Tibor, GOLDBERG, Stuart, SEITER, Karen, HARI, Parameswaran, GREINER, Jochen, VEY, Norbert, RECHER, Christian, RAVANDI, Farhad, WANG, Eunice S, RIZZIERI, David, VASCONCELLES, Michael, HUEBNER, Dirk, KANTARJIAN, Hagop M, SCHILLER, Gary, JAGASIA, Madan, STUART, Robert, GANGULY, Siddhartha, AVIGAN, David, CRAIG, Michael, COLLINS, Robert

Volltext

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial von Braun, Thorsten, Itzykson, Raphael, Renneville, Aline, de Renzis, Benoit, Dreyfus, François, Laribi, Kamel, Bouabdallah, Krimo, Vey, Norbert, Toma, Andrea, Recher, Christian, Royer, Bruno, Joly, Bertrand, Vekhoff, Anne, Lafon, Ingrid, Sanhes, Laurence, Meurice, Guillaume, Oréar, Cédric, Preudhomme, Claude, Gardin, Claude, Ades, Lionel, Fontenay, Michaela, Fenaux, Pierre, Droin, Nathalie, Solary, Eric

Volltext

Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib von Mesa, Ruben, Verstovsek, Srdan, Platzbecker, Uwe, Gupta, Vikas, Lavie, David, Giraldo, Pilar, Recher, Christian, Kiladjian, Jean-Jacques, Oh, Stephen T, Gerds, Aaron T, Devos, Timothy, Passamonti, Francesco, Vannucchi, Alessandro M, Egyed, Miklos, Lech-Maranda, Ewa, Pluta, Andrzej, Nilsson, Lars, Shimoda, Kazuya, McLornan, Donal, Kawashima, Jun, Klencke, Barbara, Huang, Mei, Strouse, Bryan, Harrison, Claire

Volltext

Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study von Pigneux, Arnaud, Béné, Marie C, Guardiola, Philippe, Recher, Christian, Hamel, Jean-Francois, Sauvezie, Mathieu, Harousseau, Jean-Luc, Tournilhac, Olivier, Witz, Francis, Berthou, Christian, Escoffre-Barbe, Martine, Guyotat, Denis, Fegueux, Nathalie, Himberlin, Chantal, Hunault, Mathilde, Delain, Martine, Lioure, Bruno, Jourdan, Eric, Bauduer, Frederic, Dreyfus, Francois, Cahn, Jean-Yves, Sotto, Jean-Jacques, Ifrah, Norbert

Volltext

Tyrosine Kinase Inhibitors with Intensive Chemotherapy in AML with t(9;22)(q34.1;q11.2)/ BCR::ABL1 : Time to Reconsider Prognostic Risk? a Study from the Dataml Registry von Gondran, Camille, Dumas, Pierre-Yves, Bidet, Audrey, Bérard, Emilie, Tavitian, Suzanne, Leguay, Thibaut, Huguet, Françoise, Luquet, Isabelle, Klein, Émilie, Sarry, Audrey, De Grande, Anne-Charlotte, Delabesse, Eric, Forcade, Édouard, Borel, Cécile, Pigneux, Arnaud, Recher, Christian, Largeaud, Laetitia, Bertoli, Sarah

Volltext

ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides von Cerella, Claudia, Gajulapalli, Sruthi Reddy, Lorant, Anne, Gerard, Deborah, Muller, Florian, Lee, Yejin, Kim, Kyung Rok, Han, Byung Woo, Christov, Christo, Récher, Christian, Sarry, Jean-Emmanuel, Dicato, Mario, Diederich, Marc

Volltext